These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2261452)

  • 1. Transformation of glucocorticoid receptors bound to the antagonist RU 486: effects of alkaline phosphatase.
    Gruol DJ; Wolfe KA
    Biochemistry; 1990 Aug; 29(34):7958-66. PubMed ID: 2261452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vivo activation of triamcinolone acetonide- and RU 38486-receptor complexes in the CEM-C7 and IM-9 human leukemic cell lines.
    Schmidt TJ
    Cancer Res; 1989 Aug; 49(16):4390-5. PubMed ID: 2743328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical characterization of the activated and non-activated forms of the glucocorticoid-receptor complex bound to the steroid antagonist [3H]RU 486.
    Sablonniere B; Danze PM; Formstecher P; Lefebvre P; Dautrevaux M
    J Steroid Biochem; 1986 Nov; 25(5A):605-14. PubMed ID: 3795940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformed glucocorticoid receptors consist of multiple subspecies with differing capacities to bind DNA-cellulose.
    Gruol DJ; Wolfe KA
    Biochemistry; 1989 Apr; 28(7):2929-36. PubMed ID: 2742821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors.
    Beck CA; Estes PA; Bona BJ; Muro-Cacho CA; Nordeen SK; Edwards DP
    Endocrinology; 1993 Aug; 133(2):728-40. PubMed ID: 8344212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activation of rat cardiac glucocorticoid antagonist- versus agonist-receptor complexes.
    Schmidt TJ; Diehl EE
    Biochim Biophys Acta; 1988 Jun; 970(2):212-21. PubMed ID: 3382699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activation and DNA binding affinity of human lymphoid (CEM-C7) cytoplasmic receptors labeled with the antiglucocorticoid RU 38486.
    Schmidt TJ
    J Steroid Biochem; 1986 Apr; 24(4):853-63. PubMed ID: 2871233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor monoclonal antibodies define the biological action of RU 38486 in intact B16 melanoma cells.
    Lindemeyer RG; Robertson NM; Litwack G
    Cancer Res; 1990 Dec; 50(24):7985-91. PubMed ID: 2253240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486.
    Gruol DJ; Altschmied J
    Mol Endocrinol; 1993 Jan; 7(1):104-13. PubMed ID: 8383286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding properties of glucocorticosteroid receptors bound to the steroid antagonist RU-486.
    Bourgeois S; Pfahl M; Baulieu EE
    EMBO J; 1984 Apr; 3(4):751-5. PubMed ID: 6327286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of glucocorticoid receptor subspecies binding to DNA-cellulose and isolated nuclei.
    Gruol DJ; Wolfe KA; Safarian S
    J Steroid Biochem; 1989; 34(1-6):319-23. PubMed ID: 2626025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that dephosphorylation inactivates glucocorticoid receptors.
    Nielsen CJ; Sando JJ; Pratt WB
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1398-402. PubMed ID: 266181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic glucocorticoid receptor behaves differently when its hormone binding site is occupied by agonist (triamcinolone acetonide) or antagonist (RU486) steroid ligands.
    Moudgil VK; Gunda M
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1239-47. PubMed ID: 1996987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of specific transcription and DNA binding studies suggest that in vitro transformed RU 486-glucocorticosteroid receptor complexes display agonist activity.
    Schweizer-Groyer G; Cadepond F; Groyer A; Idziorek T; Mariller M; Baulieu EE
    J Steroid Biochem; 1988; 30(1-6):291-4. PubMed ID: 3386256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of glucocorticoid and progesterone receptors to the DNA-binding state.
    Pratt WB
    J Cell Biochem; 1987 Sep; 35(1):51-68. PubMed ID: 3312247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum fluoride inhibition of glucocorticoid receptor inactivation and transformation.
    Housley PR
    Biochemistry; 1990 Apr; 29(14):3578-85. PubMed ID: 2191718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the glucocorticoid-receptor complex.
    Schmidt TJ; Barnett CA; Litwack G
    J Cell Biochem; 1982; 20(1):15-27. PubMed ID: 6761347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucocorticoid antagonist 17 alpha-methyltestosterone binds to the 10 S glucocorticoid receptor and blocks agonist-mediated dissociation of the 10 S oligomer to the 4 S deoxyribonucleic acid-binding subunit.
    Raaka BM; Finnerty M; Samuels HH
    Mol Endocrinol; 1989 Feb; 3(2):332-41. PubMed ID: 2710136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid hormone stimulation of Na+ transport in A6 cells is mediated via glucocorticoid receptors.
    Schmidt TJ; Husted RF; Stokes JB
    Am J Physiol; 1993 Apr; 264(4 Pt 1):C875-84. PubMed ID: 8476020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.
    Lefebvre P; Formstecher P; Richard C; Dautrevaux M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1221-9. PubMed ID: 3342067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.